Fig. 1From: Drug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph theoryWorkflow of this study, which consists of (1) identification of DEGs, (2) machine learning approach, (3) topological parameter-based classification, (4) common pathway analysis, (5) common drug analysis and (6) effectiveness verificationBack to article page